| Other intermediates | |||
| NO. | Intermediate Name | CAS NO | API/END USE |
| 1 | N,N-Dimethyl-3-phenyl-3-(O-tolyloxy)propan-1-amine oxalate | 107688-86-8 | Atomoxetine |
| 2 | 4-Guanidinobenzoic Acid HCl | 42823-46-1 | Camostat mesylate |
| 3 | 2-Chloro-N,N-dimethylacetamide | 2675-89-0 | |
| 4 | 4-Hydroxy Benzeneacetic Acid2-(Dimethylamino)-2-oxoethyl Ester | 59721-16-3 | |
| 5 | 3-(3-Trifluoromethylphenyl)propionic Acid | 585-50-2 | Cinacalcet |
| 6 | (R)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide | 1005450-55-4 | |
| 7 | N-(2-Hydroxyethyl) succinimide | 18190-44-8 | Diroximel |
| 8 | N-Boc-D-phenyl glycinol | 102089-74-7 | Elagolix |
| 9 | (R)-2-(tert-butoxycarbonylamino)-2-phenylethyl methanesulfonate | 102089-75-8 | |
| 10 | 1,3-dimethyl-1H-pyrazole-4-sulfonamide | 88398-53-2 | Elexacaftor |
| 11 | 2,3-dihydrobenzo[b][1,4]dioxine-6-carbaldehyde | 29668-44-8 | Eliglustat |
| 12 | (S)-(+)-2-Phenylglycinol | 20989-17-7 | |
| 13 | 6,7-Dihydro-9,10-dimethoxy-2-[(2,4,6-trimethylphenyl)amino]-4H-pyrimido[6,1-a]isoquinolin-4-one | 76536-66-8 | Ensifentrine |
| 14 | 4-(chloromethyl)-1-cyclopentyl 2-(trifluoromethyl)benzene | 957208-65-0 | Etrasimod |
| 15 | ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate | 1206124-13-1 | |
| 16 | 3-(N-Methyl-N-Pentyl amino)propionic acid HCl | 625120-81-2 | Ibandronate |
| 17 | Ethyl 4-Oxo-1,4-dihydroquinoline-3-carboxylate | 52980-28-6 | Ivacaftor |
| 18 | 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (USDMF No. 35586) | 13721-01-2 | |
| 19 | 5-Amino-2,4-ditert-butylphenol | 873055-58-4 | |
| 20 | 4-(chloroacetyl)-morpholine | 1440-61-5 | Lesinurad |
| 21 | 4-Chloro-1-(4-fluorophenyl)butan-1-one | 3874-54-2 | Lumateperone |
| 22 | 2-(2-Aminothiazol-4-yl)acetic acid | 29676-71-9 | Mirabegron |
| 23 | 2-(2-Aminothiazol-4-yl)acetic acid hydrochloride | 66659-20-9 | |
| 24 | 2-(4-nitrophenyl)ethanamine hydrochloride | 29968-78-3 | |
| 25 | (R)-2-(4-nitrophenethylamino)-1-Phenylethanol (USDMF No 35841) | 223673-34-5 | |
| 26 | (R)-2-(4-nitrophenethylamino)-1-phenylethanol hydrochloride | 521284-21-9 | |
| 27 | (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | 391901-45-4 | |
| 28 | (R)-2-(4-aminophenethylamino)-1-Phenylethanol hydrochloride | 521284-22-0 | |
| 29 | 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one | 27387-31-1 | Ondansetron |
| 30 | 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one HCl | 119812-29-2 | |
| 31 | 4-(6-Fluoro-1,2-benzisoxazole-3yl)-Piperidine Hydrochloride | 84163-13-3 | Paliperidone/ Risperidone |
| 32 | 4-[2,4-Difluoro benzoyl]Piperidine hydrochloride | 106266-04-0 | |
| 33 | 3-(Benzyloxy)pyridine-2-amine | 24016-03-3 | |
| 34 | 3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]-pyrididine-4-one | 63234-80-0 | |
| 35 | 2-Benzyl acrylic acid | 5669-19-2 | Racecadotril |
| 36 | Benzyl glycinate p-toluene sulfonate | 1738-76-7 | |
| 37 | 3-Amino-6-methoxy pyridazine | 7252-84-8 | Relugolix |
| 38 | Isonipecotamide/4-Piperidinecarboxamide | 39546-32-2 | Revefenacin |
| 39 | 3-Quinuclidinone hydrochloride | 1193-65-3 | Solifenacin |
| 40 | 4-[2-hydroxyethyl]phenol | 501-94-0 | Tyrosol |
| 41 | 4-chloro-7H-pyrrolo[2,3-d]pyrimidine | 3680-69-1 | Tofacitinib/ Barcitinib/ Ruxolitinib |
| 42 | 4-bromo-7Hpyrrolo[2,3D]pyrimidine | 889939-42-8 | |
| 43 | 2,4-Dichloro-1H-pyrrolo[2,3-D]pyrimidine | 90213-66-4 | |
| 44 | 3-Cyclopentylacrylonitrile | 591769-05-0 | |
| 45 | Cyclopentanecarboxaldehyde | 872-53-7 | |
| 46 | Bromoacetaldehyde Diethyl Acetal | 2032-35-1 | |
| 47 | 2-Bromo-1,1-dimethoxyethane | 7252-83-7 | |
| 48 | Formamidine acetate | 3473-63-0 | |
| 49 | 2-Fluorbenzoesure | 445-29-4 | Ataluren |
| 50 | 2-Fluorobenzoyl chloride | 393-52-2 | |
| 51 | 3-Methylbenzimidamide | 18465-28-6 | |
| 52 | 3-MethoxycarbonylbenzaMidoxiMe | 775304-79-5 | |
| 53 | Methyl 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoate | 775304-60-4 | |
| 54 | 3-(N-2-Fluorobenzoylcarbamimidoyl)-benzoicacidmethylester | 775304-80-8 | |
| 55 | Ataluren | 775304-57-9 | |
| 56 | 4-BroMo-2,6-diMethylaniline | 24596-19-8 | Orforglipron |
| 57 | 1,2-Hydrazinedicarboxylic acid, 1-(4-fluoro-3,5-dimethylphenyl)-, 1,2-bis(1,1-dimethylethyl) ester | 2212021-55-9 | |
| 58 | (4-Fluoro-3,5-dimethylphenyl)hydrazine hydrochloride | 2212021-40-2 | |
| 59 | 5-Bromo-4-fluoro-1-methylindazole | 1784678-61-0 | |
| 60 | (R)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide | 1006381-03-8 | |
| 61 | 2-(Bromomethyl)-5-(trifluoromethyl)furan | 17515-77-4 | Dolutegravir |
| 62 | 5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde | 881674-56-2 | Vonoprazan |
| 63 | Ethyl 3-chloro-2,4,5-trifluorobenzoylacetate | 101987-86-4 | Sitafloxacin |
| 64 | 4-[5-(4-Pentyloxyphenyl)isoxazol-3-yl]benzoic acid | 179162-55-1 | Micafungin |
| 65 | 4''-(Pentyloxy)-[1,1':4',1''-terphenyl]-4-carboxylic acid | 158938-08-0 | Anidulafungin |
| 66 | N-(4-glycyl-5-methoxy-2-phenoxyphenyl)methanesulfonamide hydrochloride | 149436-41-9 | Iguratimod |
| 67 | 1,4,7-Trimethyl-1,4,7-Triazacyclononane | 96556-05-7 | Others |
| 68 | BOC-L-Glutamine | 13726-85-7 | |
| 69 | (S)-Dimethyl 2-((tert-butoxycarbonyl)amino)pentanedioate | 59279-60-6 | |
| 70 | 1-Methylpiperidine-4-carboxamide | 62718-28-9 | |
| 71 | 1-methylpiperidine-4-carbonitrile | 20691-92-3 | |
| 72 | (1-Methylpiperidin-4-Yl)Methanamine | 7149-42-0 | |
Disclaimer:Products are only available to countries where there is no valid patent protection. Products still covered by patents rights are available exclusively for experimental or registration purpose pursuant to national applicable law, and shall be sold in strict accordance with the laws of the People's Republic of China and the laws of the Buyer's country. All products are not for human use. Buyer is obligated for evaluation of the patent situation in its domestic market and shall be held liable for uses which do not fall within the scope of the experimental or registration use exception and are not permitted by national applicable law.